Xponance’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Xponance's HALO Position: Q2 2026 in Review
Xponance reduced its Halozyme (HALO) stake by 1.9% in Q2 2026, selling an estimated $34.4K and leaving 25,535 shares worth $2M. The position accounts for 0.01% of the portfolio, ranked #590.
Xponance first reported a position in HALO in Q4 2020 and has held it in 23 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Xponance held 25,535 shares of Halozyme worth $2M as of Q2 2026.
- Xponance sold 504 Halozyme shares in Q2 2026, an estimated $34.4K.
- Halozyme made up 0.01% of Xponance's portfolio in Q2 2026, its #590 holding.
- Xponance first reported a position in Halozyme in Q4 2020 and has held it in 23 quarters since.
- 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.